Schering-Plough
SGP
#508
Rank
C$64.40 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Revenue for Schering-Plough (SGP)

Revenue in 2008: C$25.79 Billion

In 2008 the company made a revenue of C$25.79 Billion.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Schering-Plough from 1996 to 2008

Annual revenue

Year Revenue Change
2008C$25.79 B
2006C$14.77 B11.42%
2005C$13.25 B14.94%
2004C$11.53 B-0.74%
2003C$11.62 B-18.13%
2002C$14.19 B3.86%
2001C$13.66 B-0.13%
2000C$13.68 B6.96%
1999C$12.79 B13.61%
1998C$11.26 B19.16%
1997C$9.45 B19.84%
1996C$7.88 B